Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance of in Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram-negative Pathogens Isolated in Russia

NCT04679610 is registered in ClinicalTrials.gov with The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) as lead sponsor.

NCT NCT04679610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04679610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance of in Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram-negative Pathogens Isolated in Russia
Lead sponsor
The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
December 1, 2020
Enrollment
700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nosocomial infection